The study to compare the hypoxic imaging of 18F-FAZA-PET/CT with the glucose metabolic imaging of 18F-FDG-PET/CT in patients with tumor

The study to compare the hypoxic imaging of 18F-FAZA-PET/CT with the glucose metabolic imaging of 18F-FDG-PET/CT in patients with tumor - The comparison study between 18F-FAZA-PET/CT and 18F-FDG-PET/CT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022799

Enrollment

160

Registered

2016-07-01

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumors

Interventions

The 18F-FAZA-PET/CT examination is performed in patient with malignant tumor before and after therapy The 18F-FDG-PET/CT examination is performed in patient with malignant tumor before and after thera

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with malignant tumor who will be performed treatment

Exclusion criteria

Exclusion criteria: Patients with malignant tumor who will not be performed treatment

Design outcomes

Primary

Measure	Time frame
We compare the18F-FAZA-PET/CT findings with 18F-FDG-PET/CT findings before and after therapy in patients with malignant tumor.	—

Secondary

Measure	Time frame
Assessment of changes of the visual findings of both PET/CT examinations before and after therapy Assessment of changes of the quantitative parameters (SUV, MTV and TLG) of both PET/CT examinations before and after therapy	—

Countries

Japan

Contacts

Public ContactYoriko Kajiya

Nanpuh Hospital Radiology

toyo.nakajo@dolphin.ocn.ne.jp099-226-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026